All
Announcements
Press
Publications
Arbele logo (full)
2023-08-02
Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society...
20230505-154259_1_l
2023-05-05
Arbele celebrates its 7th anniversary as a clinical-stage immunotherapy biotech and the opening of TibTech,...
20230303-121517_1_l
2023-02-28
Arbele has entered a joint venture with the Chinese Manufacturers’ Association of Hong Kong (CMA) with...
Arbele logo (full)
2023-02-09
The diagnostic significance of CDH17-positive circulating tumor cells in patients with colorectal cancer
20221007-132617_1_l
2022-10-24
Arbele CEO Dr. John Luk, attended and presented at the Global Summit and Award Ceremonies for Cancer...
20220928-171423_1_l
2022-09-28
嘉立醫療科技於2022年港澳台創新創業大賽榮獲二等獎 / Caleb won 2nd prize at Hong Kong, Macao and Taiwan Innovation and Entrepreneurship...
20220811-043106_1_l
2022-08-10
Arbele Announces Phase 1 First-in-Human Study of CDH17xCD3 Bispecific T-Cell Engager for Treatment of...
20220509-134636_1_l
2022-04-11
Arbele has been Inducted in the Hong Kong Tech 300 Angel Fund Program
20220509-140458_1_l
2022-04-03
Arbele Diagnostic Lab at CMA has Acquired the ISO9001 Accreditation
20210712-020510_1_l
2021-05-01
Global Business Leaders Magazine
Load More
error: Content is protected !!